- Home
- Publications
- Publication Search
- Publication Details
Title
What Is Recent in Pancreatic Cancer Immunotherapy?
Authors
Keywords
-
Journal
Biomed Research International
Volume 2013, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2012-12-27
DOI
10.1155/2013/492372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the assessment and control of the effector functions of therapeutic antibodies
- (2011) Xu-Rong Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine
- (2010) Ghassan K. Abou-Alfa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Current strategies to target p53 in cancer
- (2010) Fang Chen et al. BIOCHEMICAL PHARMACOLOGY
- Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
- (2010) L. M. Weiner et al. Cancer Prevention Research
- Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express -Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
- (2010) T. Deguchi et al. CANCER RESEARCH
- DNA Vaccination: Using the Patient's Immune System to Overcome Cancer
- (2010) Georg Eschenburg et al. Clinical & Developmental Immunology
- Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions
- (2010) Shigeo Koido et al. CLINICAL IMMUNOLOGY
- MUC1 immunotherapy
- (2010) Richard E Beatson et al. Immunotherapy
- A novel high-affinity human monoclonal antibody to mesothelin
- (2010) Mitchell Ho et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
- (2010) Weidong Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas
- (2010) Xiao-Na Fan et al. PATHOLOGY RESEARCH AND PRACTICE
- Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts
- (2009) C. Larbouret et al. ANNALS OF ONCOLOGY
- Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine
- (2009) Yefei Rong et al. BMC CANCER
- HER2 overexpression correlates with survival after curative resection of pancreatic cancer
- (2009) Masahiro Komoto et al. CANCER SCIENCE
- Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
- (2009) Motoki Miyazawa et al. CANCER SCIENCE
- Survivin: A new target for anti-cancer therapy
- (2009) Bríd M. Ryan et al. CANCER TREATMENT REVIEWS
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer
- (2009) F. Mc. Johnston et al. CLINICAL CANCER RESEARCH
- Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
- (2009) S. Mocellin et al. CURRENT MEDICINAL CHEMISTRY
- Synthetic Peptide-Based Cancer Vaccines: Lessons Learned and Hurdles to Overcome
- (2009) Caroline Voskens et al. CURRENT MOLECULAR MEDICINE
- Cancer immunotherapy by fusions of dendritic cells and tumor cells
- (2009) Shigeo Koido et al. Immunotherapy
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Efficacy of Trastuzumab in Nude Mice Orthotopically Xenografted With Human Pancreatic Tumor Cells Expressing Low Levels of HER-2/neu
- (2009) Graziella Pratesi et al. JOURNAL OF IMMUNOTHERAPY
- A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
- (2009) Y. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer
- (2009) Kamigaki ONCOLOGY REPORTS
- The αGal HyperAcute®Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal-Mediated Zoonotic Blockade
- (2009) R. B. Mandell et al. Zoonoses and Public Health
- Structure of human α-enolase (hENO1), a multifunctional glycolytic enzyme
- (2008) Hyo Jin Kang et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients
- (2008) I. Hellstrom et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
- (2008) Antoun Toubaji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Immunogenicity of the hTERT540-548 Peptide in Cancer
- (2008) L. Wenandy et al. CLINICAL CANCER RESEARCH
- Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Targeted Therapies to Improve Tumor Immunotherapy
- (2008) J. Begley et al. CLINICAL CANCER RESEARCH
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Peptide-based vaccines for cancer: realizing their potential
- (2008) Shreya Kanodia et al. Expert Review of Vaccines
- Strategies used for MUC1 immunotherapy: human clinical studies
- (2008) Choon-Kit Tang et al. Expert Review of Vaccines
- Cell fusion: from hybridoma to dendritic cell-based vaccine
- (2008) Jianlin Gong et al. Expert Review of Vaccines
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
- (2008) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Releasable PEGylation of proteins with customized linkers
- (2007) David Filpula et al. ADVANCED DRUG DELIVERY REVIEWS
- The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
- (2007) Bruce A. Macher et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started